Live tape.Join the lounge

Research with context.

A clearer way to explore the market.

Create an account Contact the team

Market signals, research, watchlists, and alerts in one workspace.

Follow the signal.

Product Pricing FAQ

Data coverage Methodology Disclosures Contact

© 2026 Longbrunch. All rights reserved.

longbrunch/

RARE Markets Signal, Research & Overview - Longbrunch

ULTRAGENYX PHARMACEUTICAL IN

RAREEquity

$24.91

— (—)

TradeShort termMedium termLong term

Quick Read

Loading chart...

Volume1,537,401

Market Cap$2.45B

Weak

Company profile · Data pending

Symbol: RARE
Exchange: NMS
Currency: USD

Company profile →

Timing · 1D

Technicals

Summary

Sell

22

20 2 5

Oscillators

Neutral

45

5 1 4

Moving averages

Strong Sell

9

15 1 1

Indicator details →

Signal & events

Model signalUnavailable

EarningsAug 4, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$2.45B

Growth and income

Eps-6.1

Free Cash Flow$-219.09M

Net Income$-185M

Profitability

Ebitda$-497M

Gross Profit$106M

Balance sheet

Free Cash Flow$-219.09M

Total Assets$1.3B

Total Liabilities$1.53B

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

RelationshipsLoading

Observed associations

Relationships

RAREDNLIPCVXIONS

DNLIDENALI THERAPEUTICS INC+0.00%Residual co-movement · Market co-movement PCVXVAXCYTE INC+0.00%Residual co-movement · Market co-movement IONSIONIS PHARMACEUTICALS INC+0.00%Residual co-movement · Market co-movement KURAKURA ONCOLOGY INC+0.00%Market co-movement · Residual co-movement AVBPARRIVENT BIOPHARMA INC+0.00%Residual co-movement · Market co-movement